Stay up to date with the latest news about our innovation initiatives

Published on 20/07/2022

AlmirallShare 7th call is out now!

AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases

Published on 20/05/2022

Innovative therapies for vitiligo

Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo

Published on 20/03/2022

Understanding hidradenitis suppurativa

Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa

Published on 20/01/2022

Glue degraders for skin diseases

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases